Centene Corporation (NYSE:CNC), a leading multi-national healthcare enterprise with a market capitalization of $28.2 billion, has been the subject of intense scrutiny from Wall Street analysts in ...

This conjecture is not overly bullish as well, as similarly observed in UNH's ongoing recovery from the May 2025 P/E bottom ...

Centene (CNC): A Hidden Gem in the Healthcare Sector? An In-Depth Analysis of Its Market Value. Link: These companies may deliver higher future returns at reduced risk. Centene's Financial ...

Our no-moat rating for Centene is informed by an analysis of potential changes to the US healthcare system, which currently appear focused on the company's key end markets: Medicaid and the ...

Centene Corporation (CNC) Investors See Over $11 Billion Of Shareholder Value Wiped Out In 1 Day Amid Independent Actuary Data, Withdrawn 2025 Guidance- Hagens Berman Provided by PR Newswire Jul 7 ...

Stocks Analysis by Zacks Investment Research covering: S&P 500, Centene Corp. Read Zacks Investment Research's latest article on Investing.com ...

One stock to keep an eye on is Centene (CNC). CNC is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock is trading with a P/E ratio of 10.42, which compares to its ...

Stocks Analysis by Zacks Investment Research covering: Centene Corp. Read Zacks Investment Research's latest article on Investing.com ...

The $215 million settlement amounts to twice the value of Centene's inflated prices, according to Bonta. More than 20 states are investigating or have investigated Centene's Medicaid pharmacy billing.